Current insights into human pathogenic phenuiviruses and the host immune system

References

• Kuhn JH, Adkins S, Agwanda BR, et al. Taxonomic update of phylum negarnaviricota (Riboviria: Orthornavirae), including the large orders bunyavirales and Mononegavirales. Arch Virol. 2021 Dec;166(12):3513–17. doi: 10.1007/s00705-021-05143-6.
   PubMed Web of Science ®Google Scholar
• Daubney R, Hudson J, Garnham P. Enzootic hepatitis or rift valley fever: an undescribed virus disease of sheep, cattle, and man from East Africa. Pathol And Bacteriol. 1931;34(4):545–579. doi: 10.1002/path.1700340418
   Google Scholar
• Tigoi C, Sang R, Chepkorir E, et al. High risk for human exposure to rift valley fever virus in communities living along livestock movement routes: a cross-sectional survey in Kenya. PLOS Negl Trop Dis. 2020;14(2):e0007979. doi: 10.1371/journal.pntd.0007979
   PubMed Web of Science ®Google Scholar
• Yu XJ, Liang MF, Zhang SY, et al. Fever with thrombocytopenia associated with a novel bunyavirus in China. N Engl J Med. 2011;364(16):1523–1532. doi: 10.1056/NEJMoa1010095
   PubMed Web of Science ®Google Scholar
• 2018 annual review of diseases prioritized under the research and development blueprint. WHO Research and Development Blueprint; 2018. Available from: http://www.who.int/emergencies/diseases/2018prioritization-report.pdf
   Google Scholar
• Bird BH, Githinji JW, Macharia JM, et al. Multiple virus lineages sharing recent common ancestry were associated with a large rift valley fever outbreak among livestock in Kenya during 2006-2007. J Virol. 2008;82(22):11152–11166. doi: 10.1128/JVI.01519-08
   PubMed Web of Science ®Google Scholar
• Madani TA, Al-Mazrou YY, Al-Jeffri MH, et al. Rift Valley fever epidemic in Saudi Arabia: epidemiological, clinical, and laboratory characteristics. Clin Infect Dis. 2003;37(8):1084–1092. doi: 10.1086/378747
   PubMed Web of Science ®Google Scholar
• Centers for Disease C, Prevention. Outbreak of Rift Valley fever–Saudi Arabia, August-October, MMWR Morb Mortal Wkly Rep. 2000;49(40):905–908.
   PubMedGoogle Scholar
• Nicholas DE, Jacobsen KH, Waters NM. Risk factors associated with human rift valley fever infection: systematic review and meta-analysis. Trop Med Int Health. 2014;19(12):1420–1429. doi: 10.1111/tmi.12385
   PubMed Web of Science ®Google Scholar
• Ikegami T, Makino S. The pathogenesis of rift valley fever. Viruses. 2011;3(5):493–519. doi: 10.3390/v3050493
   PubMed Web of Science ®Google Scholar
• Wilson LR, McElroy AK. Rift valley fever virus encephalitis: viral and host determinants of pathogenesis. Annu Rev Virol. 2024. doi: 10.1146/annurev-virology-093022-011544
   PubMedGoogle Scholar
• Ebogo-Belobo JT, Kenmoe S, Abanda NN, et al. Contemporary epidemiological data of Rift Valley fever virus in humans, mosquitoes and other animal species in Africa: a systematic review and meta-analysis. Vet Med Sci. 2023;9(5):2309–2328. doi: 10.1002/vms3.1238
   PubMed Web of Science ®Google Scholar
• Sato Y, Mekata H, Sudaryatma PE, et al. Isolation of severe fever with thrombocytopenia syndrome virus from various tick species in area with human severe fever with thrombocytopenia syndrome cases. Vector-Borne Zoonot. 2021;21(5):378–384. doi: 10.1089/vbz.2020.2720
   PubMed Web of Science ®Google Scholar
• Luo LM, Zhao L, Wen HL, et al. Haemaphysalis longicornis ticks as reservoir and vector of severe fever with thrombocytopenia syndrome virus in China. Emerg Infect Dis. 2015;21(10):1770–1776. doi: 10.3201/eid2110.150126
   PubMed Web of Science ®Google Scholar
• Fang LZ, Xiao X, Lei SC, et al. Ticks as a competent vector of severe fever with thrombocytopenia syndrome virus. Ticks Tick-Borne Dis. 2023;14(2):14. doi: 10.1016/j.ttbdis.2022.102100
   Web of Science ®Google Scholar
• Kim KH, Yi J, Kim G, et al. Severe fever with thrombocytopenia syndrome, South Korea, Emerg Infect Dis 2013; 2012;19(11):1892–1894. doi: 10.3201/eid1911.130792
   Web of Science ®Google Scholar
• Takahashi T, Maeda K, Suzuki T, et al. The first identification and retrospective study of severe fever with thrombocytopenia syndrome in Japan. J Infect Dis. 2014;209(6):816–827. doi: 10.1093/infdis/jit603
   PubMed Web of Science ®Google Scholar
• Tran XC, Yun Y, Van an L, et al. Endemic severe fever with thrombocytopenia syndrome, Vietnam. Emerg Infect Dis. 2019;25(5):1029–1031. doi: 10.3201/eid2505.181463
   PubMed Web of Science ®Google Scholar
• Ongkittikul S, Watanawong R, Rompho P. Severe fever with thrombocytopenia syndrome virus: the first case report in Thailand. BKK Med J. 2020 Sep 25;16(2):204. doi: 10.31524/bkkmedj.2020.22.001
   Google Scholar
• Zohaib A, Zhang J, Saqib M, et al. Serologic evidence of severe fever with thrombocytopenia syndrome virus and related viruses in Pakistan. Emerg Infect Dis. 2020;26(7):1513–1516. doi: 10.3201/eid2607.190611
   PubMed Web of Science ®Google Scholar
• Rainey T, Occi JL, Robbins RG, et al. Discovery of haemaphysalis longicornis (Ixodida: Ixodidae) parasitizing a sheep in New Jersey, United States. J Med Entomol. 2018;55(3):757–759. doi: 10.1093/jme/tjy006
   PubMed Web of Science ®Google Scholar
• Liu Y, Li Q, Hu WF, et al. Person-to-person transmission of severe fever with thrombocytopenia syndrome virus. Vector-Borne Zoonot. 2012;12(2):156–160. doi: 10.1089/vbz.2011.0758
   PubMed Web of Science ®Google Scholar
• Bao CJ, Qi X, Wang H. A novel bunyavirus in China. N Engl J Med. 2011;365:862–863.
   PubMed Web of Science ®Google Scholar
• Zhou C-M, Qi R, Qin X-R, et al. Oral and ocular transmission of severe fever with thrombocytopenia syndrome virus. Infect Med. 2022;1(1):2–6. doi: 10.1016/j.imj.2021.12.002
   Google Scholar
• Mo Q, Xu Z, Deng F, et al. Host restriction of emerging high-pathogenic bunyaviruses via MOV10 by targeting viral nucleoprotein and blocking ribonucleoprotein assembly. PLOS Pathog. 2020;16(12):e1009129. doi: 10.1371/journal.ppat.1009129
   PubMed Web of Science ®Google Scholar
• Wichgers Schreur PJ, Kortekaas J, Palese P. Single-molecule FISH reveals non-selective packaging of rift valley fever virus genome segments. PLOS Pathog. 2016;12(8):e1005800. doi: 10.1371/journal.ppat.1005800
   PubMed Web of Science ®Google Scholar
• Liu J, Xu M, Tang B, et al. Single-particle tracking reveals the sequential entry process of the bunyavirus severe fever with thrombocytopenia syndrome virus. Small. 2019;15(6):e1803788. doi: 10.1002/smll.201803788
   PubMed Web of Science ®Google Scholar
• Koch J, Xin Q, Tischler ND, et al. Entry of phenuiviruses into mammalian Host cells. Viruses. 2021;13(2):299. doi: 10.3390/v13020299
   PubMed Web of Science ®Google Scholar
• Albornoz A, Hoffmann AB, Lozach PY, et al. Early bunyavirus-host cell interactions. Viruses. 2016;8(5):143. doi: 10.3390/v8050143
   PubMed Web of Science ®Google Scholar
• Schwarz MM, Price DA, Ganaie SS, et al. Oropouche orthobunyavirus infection is mediated by the cellular host factor Lrp1. Proc Natl Acad Sci USA. 2022;119(33):e2204706119. doi: 10.1073/pnas.2204706119
   PubMed Web of Science ®Google Scholar
• Ganaie SS, Schwarz MM, McMillen CM, et al. Lrp1 is a host entry factor for rift valley fever virus. Cell. 2021;184(20):5163–78 e24. doi: 10.1016/j.cell.2021.09.001
   PubMed Web of Science ®Google Scholar
• Zhang L, Peng X, Wang Q, et al. CCR2 is a host entry receptor for severe fever with thrombocytopenia syndrome virus. Sci Adv. 2023;9(31):eadg6856. doi: 10.1126/sciadv.adg6856
   PubMed Web of Science ®Google Scholar
• Liu T, Li J, Liu Y, et al. SNX11 identified as an essential Host factor for SFTS virus infection by CRISPR knockout screening. Virol Sin. 2019;34(5):508–520. doi: 10.1007/s12250-019-00141-0
   PubMed Web of Science ®Google Scholar
• Sun Y, Li J, Gao GF, et al. Bunyavirales ribonucleoproteins: the viral replication and transcription machinery. Crit Rev Microbiol. 2018;44(5):522–540. doi: 10.1080/1040841X.2018.1446901
   PubMed Web of Science ®Google Scholar
• Lozach PY, Mancini R, Bitto D, et al. Entry of bunyaviruses into mammalian cells. Cell Host & Microbe. 2010;7(6):488–499. doi: 10.1016/j.chom.2010.05.007
   PubMed Web of Science ®Google Scholar
• Garrison AR, Radoshitzky SR, Kota KP, et al. Crimean–Congo hemorrhagic fever virus utilizes a clathrin- and early endosome-dependent entry pathway. Virology. 2013;444(1–2):45–54. doi: 10.1016/j.virol.2013.05.030
   PubMed Web of Science ®Google Scholar
• Harmon B, Schudel BR, Maar D, et al. Rift valley fever virus strain MP-12 enters mammalian host cells via caveola-mediated endocytosis. J Virol. 2012;86(23):12954–12970. doi: 10.1128/JVI.02242-12
   PubMed Web of Science ®Google Scholar
• Shi X, van Mierlo Jt, French A, et al. Visualizing the replication cycle of bunyamwera orthobunyavirus expressing fluorescent protein-tagged gc glycoprotein. J Virol. 2010;84(17):8460–8469. doi: 10.1128/JVI.00902-10
   PubMed Web of Science ®Google Scholar
• Olschewski S, Cusack S, Rosenthal M. The cap-snatching mechanism of bunyaviruses. Trends Microbiol. 2020;28(4):293–303. doi: 10.1016/j.tim.2019.12.006
   PubMed Web of Science ®Google Scholar
• Jiang XM, Xin QL, Liu K, et al. Regulation of the WNT-CTNNB1 signaling pathway by severe fever with thrombocytopenia syndrome virus in a cap-snatching manner. MBio. 2023;14(6):e0168823. doi: 10.1128/mbio.01688-23
   PubMed Web of Science ®Google Scholar
• Uckeley ZM, Moeller R, Kuhn LI, et al. Quantitative proteomics of uukuniemi virus-host cell interactions reveals GBF1 as proviral host factor for phleboviruses. Mol Cell Proteomics. 2019;18(12):2401–2417. doi: 10.1074/mcp.RA119.001631
   PubMed Web of Science ®Google Scholar
• Yan JM, Zhang WK, Yan LN, et al. Bunyavirus SFTSV exploits autophagic flux for viral assembly and egress. Autophagy. 2022;18(7):1–14. doi: 10.1080/15548627.2021.1994296
   PubMed Web of Science ®Google Scholar
• Zhou CM, Yu XJ. Unraveling the underlying interaction mechanism between dabie bandavirus and innate immune response. Front Immunol. 2021;12:676861. doi: 10.3389/fimmu.2021.676861
   PubMed Web of Science ®Google Scholar
• Min YQ, Ning YJ, Wang H, et al. A RIG-I–like receptor directs antiviral responses to a bunyavirus and is antagonized by virus-induced blockade of TRIM25-mediated ubiquitination. J Biol Chem. 2020;295(28):9691–9711. doi: 10.1074/jbc.RA120.013973
   PubMed Web of Science ®Google Scholar
• Mukherjee P, Woods TA, Moore RA, et al. Activation of the innate signaling molecule MAVS by bunyavirus infection upregulates the adaptor protein SARM1, leading to neuronal death. Immunity. 2013;38(4):705–716. doi: 10.1016/j.immuni.2013.02.013
   PubMed Web of Science ®Google Scholar
• Weber M, Gawanbacht A, Habjan M, et al. Incoming RNA virus nucleocapsids containing a 5'-triphosphorylated genome activate rig-I and Antiviral signaling. Cell Host Microbe. 2013;13(3):336–346. doi: 10.1016/j.chom.2013.01.012
   PubMed Web of Science ®Google Scholar
• Spengler JR, Patel JR, Chakrabarti AK, et al. RIG-I mediates an antiviral response to Crimean-Congo hemorrhagic fever virus. J Virol. 2015;89(20):10219–10229. doi: 10.1128/JVI.01643-15
   PubMed Web of Science ®Google Scholar
• Huang C, Kolokoltsova OA, Yun NE, et al. Junín virus infection activates the type I interferon pathway in a RIG-I-Dependent manner. PLOS Negl Trop Dis. 2012;6(5):e1659. doi: 10.1371/journal.pntd.0001659
   PubMed Web of Science ®Google Scholar
• Ermler ME, Yerukhim E, Schriewer J, et al. RNA helicase signaling is critical for type i interferon production and protection against rift valley fever virus during mucosal challenge. J Virol. 2013;87(9):4846–4860. doi: 10.1128/JVI.01997-12
   PubMed Web of Science ®Google Scholar
• Habjan M, Andersson I, Klingstrom J, et al. Processing of genome 5' termini as a strategy of negative-strand RNA viruses to avoid RIG-I-Dependent interferon induction. PLOS ONE. 2008;3(4):e2032. doi: 10.1371/journal.pone.0002032
   PubMed Web of Science ®Google Scholar
• Yamada S, Shimojima M, Narita R, et al. RIG-I-Like receptor and toll-like receptor signaling pathways cause aberrant production of inflammatory Cytokines/Chemokines in a severe fever with thrombocytopenia syndrome virus infection mouse Model. J Virol. 2018;92(13). doi: 10.1128/JVI.02246-17
   Web of Science ®Google Scholar
• Wu X, Qi X, Liang M, et al. Roles of viroplasm-like structures formed by nonstructural protein NSs in infection with severe fever with thrombocytopenia syndrome virus. FASEB J. 2014;28(6):2504–2516. doi: 10.1096/fj.13-243857
   PubMed Web of Science ®Google Scholar
• Dhir A, Dhir S, Borowski LS, et al. Mitochondrial double-stranded RNA triggers antiviral signalling in humans. Nature. 2018;560(7717):238–242. doi: 10.1038/s41586-018-0363-0
   PubMed Web of Science ®Google Scholar
• Weber F, Wagner V, Rasmussen SB, et al. Double-stranded RNA is produced by positive-strand RNA viruses and DNA viruses but not in detectable amounts by negative-strand RNA viruses. J Virol. 2006;80(10):5059–5064. doi: 10.1128/JVI.80.10.5059-5064.2006
   PubMed Web of Science ®Google Scholar
• Wang H, Vaheri A, Weber F, et al. Old world hantaviruses do not produce detectable amounts of dsRNA in infected cells and the 5' termini of their genomic RNAs are monophosphorylated. Journal Of General Virology. 2011;92(5):1199–1204. doi: 10.1099/vir.0.029405-0
   PubMedGoogle Scholar
• O’Brien CA, Hobson-Peters J, Yam AW, et al. Viral RNA intermediates as targets for detection and discovery of novel and emerging mosquito-borne viruses. PLOS Negl Trop Dis. 2015;9(3):e0003629. doi: 10.1371/journal.pntd.0003629
   PubMed Web of Science ®Google Scholar
• Barr JN. Bunyavirus mRNA synthesis is coupled to translation to prevent premature transcription termination. RNA. 2007;13(5):731–736. doi: 10.1261/rna.436607
   PubMed Web of Science ®Google Scholar
• Ermler ME, Traylor Z, Patel K, et al. Rift valley fever virus infection induces activation of the NLRP3 inflammasome. Virology. 2014;449:174–180. doi: 10.1016/j.virol.2013.11.015
   PubMed Web of Science ®Google Scholar
• Li S, Li H, Zhang YL, et al. SFTSV infection induces BAK/BAX-Dependent mitochondrial DNA release to trigger NLRP3 Inflammasome activation. Cell Reports. 2020;30(13):4370–85 e7. doi: 10.1016/j.celrep.2020.02.105
   PubMed Web of Science ®Google Scholar
• Wan Q, Song D, Li H, et al. Stress proteins: the biological functions in virus infection, present and challenges for target-based antiviral drug development. Signal transduction and targeted therapy. Signal Transduct Target Ther. 2020;5(1):125. doi: 10.1038/s41392-020-00233-4
   PubMed Web of Science ®Google Scholar
• Cao L, Liu S, Li Y, et al. The nuclear matrix protein SAFA surveils viral RNA and Facilitates immunity by activating antiviral enhancers and super-enhancers. Cell Host & Microbe. 2019;26:369–84 e8. doi: 10.1016/j.chom.2019.08.010
   PubMed Web of Science ®Google Scholar
• Valente ST, Goff SP. Inhibition of HIV-1 gene expression by a fragment of hnRNP U. Mol Cell. 2006;23(4):597–605. doi: 10.1016/j.molcel.2006.07.021
   PubMed Web of Science ®Google Scholar
• Liu BY, Yu XJ, Zhou CM, et al. SAFA initiates innate immunity against cytoplasmic RNA virus SFTSV infection. PLOS Pathog. 2021;17(11):e1010070. doi: 10.1371/journal.ppat.1010070
   PubMed Web of Science ®Google Scholar
• Zz J, Chu M, Ln Y, et al. SFTSV nucleoprotein mediates DNA sensor cGAS degradation to suppress cGAS-dependent antiviral responses. Microbiol Spectr. 2024;12(6):e0379623. doi: 10.1128/spectrum.03796-23
   PubMed Web of Science ®Google Scholar
• Jia Y, Li F, Liu Z, et al. Interaction between the SFTSV envelope glycoprotein gn and STING inhibits the formation of the STING-TBK1 complex and suppresses the nf-κB signaling pathway. J Virol. 2024;98(3):e0181523. doi: 10.1128/jvi.01815-23
   PubMed Web of Science ®Google Scholar
• Rezelj L VV, Chaudhary P, Elliott V, et al. Differential antagonism of human innate immune responses by tick-borne phlebovirus nonstructural proteins. mSphere. 2017;2(3). doi: 10.1128/mSphere.00234-17
   PubMed Web of Science ®Google Scholar
• Yadani FZ, Kohl A, Prehaud C, et al. The carboxy-terminal acidic domain of rift valley fever virus NSs protein is essential for the formation of filamentous structures but not for the nuclear localization of the protein. J Virol. 1999;73(6):5018–5025. doi: 10.1128/JVI.73.6.5018-5025.1999
   PubMed Web of Science ®Google Scholar
• Billecocq A, Spiegel M, Vialat P, et al. NSs protein of rift valley fever virus blocks interferon production by inhibiting host gene transcription. J Virol. 2004;78(18):9798–9806. doi: 10.1128/JVI.78.18.9798-9806.2004
   PubMed Web of Science ®Google Scholar
• Cyr N, de la Fuente C, Lecoq L, et al. A OmegaXaV motif in the Rift Valley fever virus NSs protein is essential for degrading p62, forming nuclear filaments and virulence. Proc Natl Acad Sci U S A. 2015 May 12;112(19):6021–6026. doi: 10.1073/pnas.1503688112.
   PubMed Web of Science ®Google Scholar
• Bouloy M, Janzen C, Vialat P, et al. Genetic evidence for an interferon-antagonistic function of rift valley fever virus nonstructural protein NSs. J Virol. 2001;75(3):1371–1377. doi: 10.1128/JVI.75.3.1371-1377.2001
   PubMed Web of Science ®Google Scholar
• Vialat P, Billecocq A, Kohl A, et al. The S segment of rift valley fever phlebovirus (bunyaviridae) carries determinants for attenuation and virulence in mice. J Virol. 2000;74(3):1538–1543. doi: 10.1128/JVI.74.3.1538-1543.2000
   PubMed Web of Science ®Google Scholar
• Leger P, Nachman E, Richter K, et al. NSs amyloid formation is associated with the virulence of rift valley fever virus in mice. Nat Commun. 2020;11(1):3281. doi: 10.1038/s41467-020-17101-y
   PubMed Web of Science ®Google Scholar
• Ly HJ, Ikegami T. Rift valley fever virus NSs protein functions and the similarity to other bunyavirus NSs proteins. Virol J. 2016;13(1):118. doi: 10.1186/s12985-016-0573-8
   PubMedGoogle Scholar
• Wuerth JD, Weber F. Phleboviruses and the type I interferon response. Viruses. 2016;8(6):174. doi: 10.3390/v8060174
   PubMed Web of Science ®Google Scholar
• Barski M, Brennan B, Miller OK, et al. Rift valley fever phlebovirus NSs protein core domain structure suggests molecular basis for nuclear filaments. Elife. 2017;6:6. doi: 10.7554/eLife.29236
   Web of Science ®Google Scholar
• Kalveram B, Lihoradova O, Ikegami T. NSs protein of rift valley fever virus promotes posttranslational downregulation of the TFIIH subunit p62. J Virol. 2011;85(13):6234–6243. doi: 10.1128/JVI.02255-10
   PubMed Web of Science ®Google Scholar
• Habjan M, Pichlmair A, Elliott RM, et al. NSs protein of rift valley fever virus induces the specific degradation of the double-stranded RNA-dependent protein kinase. J Virol. 2009;83(9):4365–4375. doi: 10.1128/JVI.02148-08
   PubMed Web of Science ®Google Scholar
• Ikegami T, Narayanan K, Won S, et al. Rift valley fever virus NSs protein promotes post-transcriptional downregulation of protein kinase PKR and Inhibits eIf2α phosphorylation. PLOS Pathog. 2009;5(2):e1000287. doi: 10.1371/journal.ppat.1000287
   PubMed Web of Science ®Google Scholar
• Kainulainen M, Lau S, Samuel CE, et al. NSs virulence factor of rift valley fever virus engages the F-Box proteins FBXW11 and β-TRCP1 to degrade the antiviral protein kinase PKR. J Virol. 2016;90(13):6140–6147. doi: 10.1128/JVI.00016-16
   PubMed Web of Science ®Google Scholar
• Mudhasani R, Tran JP, Retterer C, et al. Protein kinase R degradation is essential for rift valley fever virus infection and is regulated by SKP1-CUL1-F-box (SCF)FBXW11-NSs E3 ligase. PLOS Pathog. 2016;12(2):e1005437. doi: 10.1371/journal.ppat.1005437
   PubMed Web of Science ®Google Scholar
• Terasaki K, Ramirez SI, Makino S, et al. Mechanistic insight into the host transcription inhibition function of rift valley fever virus NSs and its importance in virulence. PLOS neglected tropical diseases. PLOS Negl Trop Dis. 2016;10(10):e0005047. doi: 10.1371/journal.pntd.0005047
   PubMed Web of Science ®Google Scholar
• Weill L, Shestakova E, Bonnefoy E. Transcription factor YY1 binds to the murine beta interferon promoter and regulates its transcriptional capacity with a dual activator/repressor role. J Virol. 2003;77(5):2903–2914. doi: 10.1128/JVI.77.5.2903-2914.2003
   PubMed Web of Science ®Google Scholar
• Le May N, Mansuroglu Z, Leger P, et al. A SAP30 complex inhibits ifn-β expression in rift valley fever virus infected cells. PLOS Pathog. 2008;4(1):e13. doi: 10.1371/journal.ppat.0040013
   PubMed Web of Science ®Google Scholar
• Copeland AM, Van Deusen NM, Schmaljohn CS. Rift valley fever virus NSS gene expression correlates with a defect in nuclear mRNA export. Virology. 2015;486:88–93. doi: 10.1016/j.virol.2015.09.003
   PubMed Web of Science ®Google Scholar
• Monteiro GER, Jansen van Vuren P, Wichgers Schreur PJ, et al. Mutation of adjacent cysteine residues in the NSs protein of Rift Valley fever virus results in loss of virulence in mice. Virus Res. 2018;249:31–44. doi: 10.1016/j.virusres.2018.03.005
   PubMed Web of Science ®Google Scholar
• Gori-Savellini G, Valentini M, Cusi MG. Toscana virus NSs protein inhibits the induction of type I interferon by interacting with RIG-I. J Virol. 2013;87(12):6660–6667. doi: 10.1128/JVI.03129-12
   PubMed Web of Science ®Google Scholar
• Kalveram B, Ikegami T. Toscana virus NSs protein promotes degradation of double-stranded RNA-dependent protein kinase. J Virol. 2013;87(7):3710–3718. doi: 10.1128/JVI.02506-12
   PubMed Web of Science ®Google Scholar
• Gori Savellini G, Anichini G, Gandolfo C, et al. Toscana virus non-structural protein NSs acts as E3 ubiquitin ligase promoting RIG-I degradation. PLOS Pathog. 2019;15(12):e1008186. doi: 10.1371/journal.ppat.1008186
   PubMed Web of Science ®Google Scholar
• Moriyama M, Igarashi M, Koshiba T, et al. Two conserved amino acids within the NSs of severe fever with thrombocytopenia syndrome phlebovirus are essential for anti-interferon activity. J Virol. 2018;92(19). doi: 10.1128/JVI.00706-18
   Web of Science ®Google Scholar
• Santiago FW, Covaleda LM, Sanchez-Aparicio MT, et al. Hijacking of RIG-I signaling proteins into virus-induced cytoplasmic structures correlates with the inhibition of type I interferon responses. J Virol. 2014;88(8):4572–4585. doi: 10.1128/JVI.03021-13
   PubMed Web of Science ®Google Scholar
• Ning YJ, Wang M, Deng M, et al. Viral suppression of innate immunity via spatial isolation of TBK1/IKKε from mitochondrial antiviral platform. Journal Of Molecular Cell Biology. 2014;6(4):324–337. doi: 10.1093/jmcb/mju015
   PubMed Web of Science ®Google Scholar
• Wu X, Qi X, Qu B, et al. Evasion of antiviral immunity through sequestering of TBK1/IKKε/IRF3 into viral inclusion bodies. J Virol. 2014;88(6):3067–3076. doi: 10.1128/JVI.03510-13
   PubMed Web of Science ®Google Scholar
• Hong Y, Bai M, Qi X, et al. Suppression of the ifn-α and -β induction through sequestering IRF7 into viral inclusion bodies by nonstructural protein NSs in severe fever with thrombocytopenia syndrome bunyavirus infection. The Journal Of Immunology. 2019;202(3):841–856. doi: 10.4049/jimmunol.1800576
   PubMed Web of Science ®Google Scholar
• Ning YJ, Feng K, Min YQ, et al. Disruption of type I interferon signaling by the nonstructural protein of severe fever with thrombocytopenia syndrome virus via the hijacking of STAT2 and STAT1 into inclusion bodies. J Virol. 2015;89(8):4227–4236. doi: 10.1128/JVI.00154-15
   PubMed Web of Science ®Google Scholar
• Chaudhary V, Zhang S, Yuen KS, et al. Suppression of type I and type III IFN signalling by NSs protein of severe fever with thrombocytopenia syndrome virus through inhibition of STAT1 phosphorylation and activation. J Gen Virol. 2015;96(11):3204–3211. doi: 10.1099/jgv.0.000280
   PubMedGoogle Scholar
• Zhang L, Fu Y, Zhang R, et al. Nonstructural protein NSs hampers cellular antiviral response through LSm14A during severe fever with thrombocytopenia syndrome virus infection. The J Immunol. 2021;207(2):590–601. doi: 10.4049/jimmunol.2100148
   PubMed Web of Science ®Google Scholar
• Liu S, Liu H, Kang J, et al. The severe fever with thrombocytopenia syndrome virus NSs protein interacts with CDK1 to induce G2 cell cycle arrest and positively regulate viral replication. J Virol. 2020;94(6). doi: 10.1128/JVI.01575-19
   Web of Science ®Google Scholar
• Li ZM, Duan SH, Yu TM, et al. Bunyavirus SFTSV NSs utilizes autophagy to escape the antiviral innate immune response. Autophagy. 2024:1–13. doi: 10.1080/15548627.2024.2356505
   Web of Science ®Google Scholar
• Feng K, Zhang H, Jiang Z, et al. SFTS bunyavirus NSs protein sequestrates mTOR into inclusion bodies and deregulates mTOR-ULK1 signaling, provoking pro-viral autophagy. J Med Virol. 2023;95(1):e28371. doi: 10.1002/jmv.28371
   PubMed Web of Science ®Google Scholar
• Liu S, Su Y, Lu Z, et al. The SFTSV nonstructural proteins induce autophagy to promote viral replication via interaction with Vimentin. J Virol. 2023;97(4):e0030223. doi: 10.1128/jvi.00302-23
   PubMed Web of Science ®Google Scholar
• McMullan LK, Folk SM, Kelly AJ, et al. A new phlebovirus associated with severe febrile illness in Missouri. N Engl J Med. 2012;367(9):834–841. doi: 10.1056/NEJMoa1203378
   PubMed Web of Science ®Google Scholar
• Feng K, Deng F, Hu Z, et al. Heartland virus antagonizes type I and III interferon antiviral signaling by inhibiting phosphorylation and nuclear translocation of STAT2 and STAT1. J Biol Chem. 2019;294(24):9503–9517. doi: 10.1074/jbc.RA118.006563
   PubMed Web of Science ®Google Scholar
• Ning YJ, Feng K, Min YQ, et al. Heartland virus NSs protein disrupts host defenses by blocking the TBK1 kinase–IRF3 transcription factor interaction and signaling required for interferon induction. Journal Of Biological Chemistry. 2017;292(40):16722–16733. doi: 10.1074/jbc.M117.805127
   PubMed Web of Science ®Google Scholar
• Saikku P. Arboviruses in Finland. 3. Uukuniemi virus antibodies in human, cattle, and reindeer sera. Am J Trop Med Hyg. 1973;22(3):400–403. doi: 10.4269/ajtmh.1973.22.400
   PubMed Web of Science ®Google Scholar
• Rezelj O VV, Elliott AK, Elliott, et al. Generation of mutant uukuniemi viruses lacking the nonstructural protein NSs by reverse genetics indicates that NSs is a weak interferon antagonist. J Virol. 2015;89(9):4849–4856. doi: 10.1128/JVI.03511-14
   PubMed Web of Science ®Google Scholar
• Simons JF, Hellman U, Pettersson RF. Uukuniemi virus S RNA segment: ambisense coding strategy, packaging of complementary strands into virions, and homology to members of the genus phlebovirus. J Virol. 1990;64(1):247–255. doi: 10.1128/jvi.64.1.247-255.1990
   PubMed Web of Science ®Google Scholar
• Shen S, Duan X, Wang B, et al. A novel tick-borne phlebovirus, closely related to severe fever with thrombocytopenia syndrome virus and heartland virus, is a potential pathogen. Emerging Microbes & Infections. 2018;7:95. doi: 10.1038/s41426-018-0093-2
   PubMed Web of Science ®Google Scholar
• Min YQ, Shi C, Yao T, et al. The nonstructural protein of guertu virus disrupts Host defenses by blocking antiviral interferon induction and action. ACS Infect Dis. 2020;6(5):857–870. doi: 10.1021/acsinfecdis.9b00492
   PubMed Web of Science ®Google Scholar
• Zhao C, Zhao W. NLRP3 inflammasome-A key player in antiviral responses. Front Immunol. 2020;11:211. doi: 10.3389/fimmu.2020.00211
   PubMed Web of Science ®Google Scholar
• Swanson KV, Deng M, Ting JP. The NLRP3 inflammasome: molecular activation and regulation to therapeutics. Nat Rev Immunol. 2019;19(8):477–489. doi: 10.1038/s41577-019-0165-0
   PubMed Web of Science ®Google Scholar
• Ye W, Lei Y, Yu M, et al. NLRP3 inflammasome is responsible for hantavirus inducing interleukin-1β in THP-1 cells. International Journal Of Molecular Medicine. 2015;35(6):1633–1640. doi: 10.3892/ijmm.2015.2162
   PubMed Web of Science ®Google Scholar
• Ma R, Zhang X, Shu J, et al. Nlrc3 knockout mice showed renal pathological changes after HTNV infection. Front Immunol. 2021;12:692509. doi: 10.3389/fimmu.2021.692509
   PubMed Web of Science ®Google Scholar
• Sun Y, Jin C, Zhan F, et al. Host cytokine storm is associated with disease severity of severe fever with thrombocytopenia syndrome. J Infect Dis. 2012;206(7):1085–1094. doi: 10.1093/infdis/jis452
   PubMed Web of Science ®Google Scholar
• Liu MM, Lei XY, Yu H, et al. Correlation of cytokine level with the severity of severe fever with thrombocytopenia syndrome. Virol J. 2017;14(1):6. doi: 10.1186/s12985-016-0677-1
   PubMedGoogle Scholar
• Liu JW, Chu M, Jiao YJ, et al. SFTSV infection induced Interleukin-1beta secretion through NLRP3 Inflammasome activation. Front Immunol. 2021;12:595140. doi: 10.3389/fimmu.2021.595140
   PubMed Web of Science ®Google Scholar
• Li Z, Hu J, Bao C, et al. Activation of the NLRP3 inflammasome and elevation of interleukin-1β secretion in infection by sever fever with thrombocytopenia syndrome virus. Sci Rep. 2022;12(1):2573. doi: 10.1038/s41598-022-06229-0
   PubMed Web of Science ®Google Scholar
• Choi Y, Park SJ, Sun Y, et al. Severe fever with thrombocytopenia syndrome phlebovirus non-structural protein activates TPL2 signalling pathway for viral immunopathogenesis. Nat Microbiol. 2019;4(3):429–437. doi: 10.1038/s41564-018-0329-x
   PubMed Web of Science ®Google Scholar
• Saha S, Buttari B, Panieri E, et al. An overview of Nrf2 signaling pathway and its role in inflammation. Molecules. 2020;25(22):25. doi: 10.3390/molecules25225474
   Web of Science ®Google Scholar
• Choi Y, Jiang Z, Shin WJ, et al. Severe fever with thrombocytopenia syndrome virus NSs interacts with TRIM21 to activate the p62-Keap1-Nrf2 pathway. J Virol. 2020;94(6). doi: 10.1128/JVI.01684-19
   Web of Science ®Google Scholar
• Gao C, Yu Y, Wen C, et al. Nonstructural protein NSs activates inflammasome and pyroptosis through interaction with NLRP3 in human microglial cells infected with severe fever with thrombocytopenia syndrome bandavirus. J Virol. 2022;96(13):e0016722. doi: 10.1128/jvi.00167-22
   PubMed Web of Science ®Google Scholar
• Khalil J, Yamada S, Tsukamoto Y, et al. The nonstructural protein NSs of severe fever with thrombocytopenia syndrome virus causes a Cytokine storm through the hyperactivation of nf-κB. Mol Cell Biol. 2020;41(3). doi: 10.1128/MCB.00542-20
   PubMed Web of Science ®Google Scholar
• Mendoza CA, Yamaoka S, Tsuda Y, et al. The nf-kappaB inhibitor, SC75741, is a novel antiviral against emerging tick-borne bandaviruses. Antiviral Res. 2021;185:104993. doi: 10.1016/j.antiviral.2020.104993
   PubMed Web of Science ®Google Scholar
• Cheng Y, Sun F, Wang L, et al. Virus-induced p38 MAPK activation facilitates viral infection. Theranostics. 2020;10(26):12223–12240. doi: 10.7150/thno.50992
   PubMed Web of Science ®Google Scholar
• Lee HK, Lund JM, Ramanathan B, et al. Autophagy-dependent viral recognition by plasmacytoid dendritic cells. Science. 2007;315(5817):1398–1401. doi: 10.1126/science.1136880
   PubMed Web of Science ®Google Scholar
• Shoji-Kawata S, Sumpter R, Leveno M, et al. Identification of a candidate therapeutic autophagy-inducing peptide. Nature. 2013;494(7436):201–206. doi: 10.1038/nature11866
   PubMed Web of Science ®Google Scholar
• Orvedahl A, MacPherson S, Sumpter R Jr., et al. Autophagy protects against sindbis virus infection of the central nervous system. Cell Host & Microbe. 2010;7(2):115–127. doi: 10.1016/j.chom.2010.01.007
   PubMed Web of Science ®Google Scholar
• Chen YH, Du W, Hagemeijer MC, et al. Phosphatidylserine vesicles enable efficient en bloc transmission of enteroviruses. Cell. 2015;160(4):619–630. doi: 10.1016/j.cell.2015.01.032
   PubMed Web of Science ®Google Scholar
• Corona AK, Saulsbery HM, Velazquez AFC, et al. Enteroviruses remodel Autophagic trafficking through regulation of Host SNARE proteins to promote virus replication and cell exit. Cell Rep. 2018;22(12):3304–3314. doi: 10.1016/j.celrep.2018.03.003
   PubMed Web of Science ®Google Scholar
• Ghosh S, Dellibovi-Ragheb TA, Kerviel A, et al. β-coronaviruses use lysosomes for egress instead of the biosynthetic secretory pathway. Cell. 2020;183(6):1520–1535.e14. doi: 10.1016/j.cell.2020.10.039
   PubMed Web of Science ®Google Scholar
• Moy RH, Gold B, Molleston JM, et al. Antiviral autophagy restrictsRift valley fever virus infection and is conserved from flies to mammals. Immunity. 2014;40(1):51–65. doi: 10.1016/j.immuni.2013.10.020
   PubMed Web of Science ®Google Scholar
• Zhu X, Guan Z, Fang Y, et al. Rift valley fever virus nucleoprotein triggers autophagy to dampen antiviral innate immune responses. J Virol. 2023;97(4):e0181422. doi: 10.1128/jvi.01814-22
   PubMed Web of Science ®Google Scholar
• Yan JM, Zhang WK, Li F, et al. Integrated transcriptome profiling in THP-1 macrophages infected with bunyavirus SFTSV. Virus Res. 2021;306:198594. doi: 10.1016/j.virusres.2021.198594
   PubMed Web of Science ®Google Scholar
• Zhang LK, Wang B, Xin Q, et al. Quantitative proteomic analysis reveals unfolded-protein response involved in severe fever with thrombocytopenia syndrome virus infection. J Virol. 2019;93(10). doi: 10.1128/JVI.00308-19
   Web of Science ®Google Scholar
• Li Z, Shen Y, Song Y, et al. ER stress-related molecules induced by Hantaan virus infection in differentiated THP-1 cells. Cell Stress & Chaperones. 2021;26(1):41–50. doi: 10.1007/s12192-020-01150-9
   PubMed Web of Science ®Google Scholar
• Li XD, Lankinen H, Putkuri N, et al. Tula hantavirus triggers pro-apoptotic signals of ER stress in Vero E6 cells. Virology. 2005;333(1):180–189. doi: 10.1016/j.virol.2005.01.002
   PubMed Web of Science ®Google Scholar
• Silvas JA, Popov VL, Paulucci-Holthauzen A, et al. Extracellular vesicles mediate receptor-independent transmission of novel tick-borne bunyavirus. J Virol. 2016;90(2):873–886. doi: 10.1128/JVI.02490-15
   PubMed Web of Science ®Google Scholar
• Ahsan NA, Sampey GC, Lepene B, et al. Presence of viral RNA and Proteins in exosomes from cellular clones resistant to rift valley fever virus infection. Front Microbiol. 2016;7:139. doi: 10.3389/fmicb.2016.00139
   PubMed Web of Science ®Google Scholar
• Kerr JF, Wyllie AH, Currie AR. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer. 1972;26(4):239–257. doi: 10.1038/bjc.1972.33
   PubMed Web of Science ®Google Scholar
• Won S, Ikegami T, Peters CJ, et al. Nsm protein of rift valley fever virus suppresses virus-induced apoptosis. J Virol. 2007;81(24):13335–13345. doi: 10.1128/JVI.01238-07
   PubMed Web of Science ®Google Scholar
• Terasaki K, Won S, Makino S. The C-terminal region of Rift Valley fever virus NSm protein targets the protein to the mitochondrial outer membrane and exerts antiapoptotic function. J Virol. 2013;87(1):676–682. doi: 10.1128/JVI.02192-12
   PubMed Web of Science ®Google Scholar
• Austin D, Baer A, Lundberg L, et al. p53 activation following rift valley fever virus infection contributes to cell death and viral production. PLOS ONE. 2012;7(5):e36327. doi: 10.1371/journal.pone.0036327
   PubMed Web of Science ®Google Scholar
• Popova TG, Turell MJ, Espina V, et al. Reverse-phase phosphoproteome analysis of signaling pathways induced by rift valley fever virus in human small airway epithelial cells. PLOS ONE. 2010;5(11):e13805. doi: 10.1371/journal.pone.0013805
   PubMed Web of Science ®Google Scholar
• Narayanan A, Amaya M, Voss K, et al. Reactive oxygen species activate NFkappaB (p65) and p53 and induce apoptosis in RVFV infected liver cells. Virology. 2014;449:270–286. doi: 10.1016/j.virol.2013.11.023
   PubMed Web of Science ®Google Scholar
• Quellec J, Pedarrieu A, Piro-Megy C, et al. Rift valley fever virus modulates apoptosis and immune response during infection of human astrocytes. Emerg Microbes Infect. 2023;12(1):2207672. doi: 10.1080/22221751.2023.2207672
   PubMed Web of Science ®Google Scholar
• Michaely LM, Rissmann M, Armando F, et al. Rift valley fever virus non-structural protein S is associated with nuclear translocation of active caspase-3 and inclusion body formation. Viruses. 2022;14(11):14. doi: 10.3390/v14112487
   Web of Science ®Google Scholar
• Qu B, Qi X, Wu X, et al. Suppression of the interferon and nf-κB responses by severe fever with thrombocytopenia syndrome virus. J Virol. 2012;86(16):8388–8401. doi: 10.1128/JVI.00612-12
   PubMed Web of Science ®Google Scholar
• Song P, Zheng N, Liu Y, et al. Deficient humoral responses and disrupted B-cell immunity are associated with fatal SFTSV infection. Nat Commun. 2018;9(1):3328. doi: 10.1038/s41467-018-05746-9
   PubMed Web of Science ®Google Scholar
• Sun Q, Jin C, Zhu L, et al. Host responses and regulation by NFκB signaling in the liver and liver epithelial cells infected with a novel tick-borne bunyavirus. Sci Rep. 2015;5(1):11816. doi: 10.1038/srep11816
   PubMedGoogle Scholar
• Xu S, Jiang N, Nawaz W, et al. Infection of humanized mice with a novel phlebovirus presented pathogenic features of severe fever with thrombocytopenia syndrome. PLOS Pathog. 2021;17(5):e1009587. doi: 10.1371/journal.ppat.1009587
   PubMed Web of Science ®Google Scholar
• Liu S, Liu H, Zhang K, et al. Proteasome inhibitor PS-341 effectively blocks infection by the severe fever with thrombocytopenia syndrome virus. Virol Sin. 2019;34(5):572–582. doi: 10.1007/s12250-019-00162-9
   PubMed Web of Science ®Google Scholar
• Lozach PY, Kuhbacher A, Meier R, et al. DC-SIGN as a receptor for phleboviruses. Cell Host & Microbe. 2011;10(1):75–88. doi: 10.1016/j.chom.2011.06.007
   PubMed Web of Science ®Google Scholar
• Wonderlich ER, Caroline AL, McMillen CM, et al. Peripheral blood biomarkers of disease outcome in a monkey Model of rift valley fever encephalitis. J Virol. 2018;92(3). doi: 10.1128/JVI.01662-17
   PubMed Web of Science ®Google Scholar
• Zhang W, Li M, Xiong S, et al. Decreased myeloid dendritic cells indicate a poor prognosis in patients with severe fever with thrombocytopenia syndrome. Int J Infect Dis. 2017;54:113–120. doi: 10.1016/j.ijid.2016.11.418
   PubMed Web of Science ®Google Scholar
• Song P, Zheng N, Zhang L, et al. Downregulation of interferon-β and inhibition of TLR3 expression are associated with fatal outcome of severe fever with thrombocytopenia syndrome. Sci Rep. 2017;7(1):6532. doi: 10.1038/s41598-017-06921-6
   PubMedGoogle Scholar
• Harmon JR, Spengler JR, Coleman-McCray JD, et al. CD4 T cells, CD8 T cells, and monocytes coordinate to prevent rift valley fever virus encephalitis. J Virol. 2018;92(24). doi: 10.1128/JVI.01270-18
   PubMed Web of Science ®Google Scholar
• Hum NR, Bourguet FA, Sebastian A, et al. MAVS mediates a protective immune response in the brain to Rift Valley fever virus. PLOS Pathog. 2022;18(5):e1010231. doi: 10.1371/journal.ppat.1010231
   PubMed Web of Science ®Google Scholar
• Lu Q-B, Cui N, Hu J-G, et al. Characterization of immunological responses in patients with severe fever with thrombocytopenia syndrome: a cohort study in China. Vaccine. 2015;33(10):1250–1255. doi: 10.1016/j.vaccine.2015.01.051
   PubMed Web of Science ®Google Scholar
• Li M, Xiong Y, Li M, et al. Depletion but activation of CD56dimCD16+ NK cells in acute infection with severe fever with thrombocytopenia syndrome virus. Virol Sin. 2020;35(5):588–598. doi: 10.1007/s12250-020-00224-3
   PubMed Web of Science ®Google Scholar
• Du J, Li XK, Peng XF, et al. Expansion of granulocytic myeloid‐derived suppressor cells in patients with severe fever with thrombocytopenia syndrome. J Med Virol. 2022;94(9):4329–4337. doi: 10.1002/jmv.27854
   PubMed Web of Science ®Google Scholar
• Huang M, Wang T, Huang Y, et al. The clinical and immunological characteristics in fatal severe fever with thrombocytopenia syndrome virus (SFTSV) infection. Clin Immunol. 2023;248:248. doi: 10.1016/j.clim.2023.109262
   Web of Science ®Google Scholar
• Sun L, Hu Y, Niyonsaba A, et al. Detection and evaluation of immunofunction of patients with severe fever with thrombocytopenia syndrome. Clin Exp Med. 2013;14(4):389–395. doi: 10.1007/s10238-013-0259-0
   PubMed Web of Science ®Google Scholar
• Dodd KA, Ak M, Jones ME, et al. Rift valley fever virus clearance and protection from neurologic disease are dependent on CD4+ T cell and virus-specific antibody responses. J Virol. 2013;87(11):6161–6171. doi: 10.1128/JVI.00337-13
   PubMed Web of Science ®Google Scholar
• Park A, Park SJ, Jung KL, et al. Molecular signatures of inflammatory profile and B-Cell function in patients with severe fever with thrombocytopenia syndrome. MBio. 2021;12(1):12. doi: 10.1128/mBio.02583-20
   Web of Science ®Google Scholar
• Zhang J, Yan X, Li Y, et al. Reactive plasmacytosis mimicking multiple myeloma associated with SFTS virus infection: a report of two cases and literature review. BMC Infect Dis. 2018;18(1):18. doi: 10.1186/s12879-018-3431-z
   PubMedGoogle Scholar
• Takahashi T, Suzuki T, Hiroshige S, et al. Transient appearance of plasmablasts in the peripheral blood of Japanese patients with severe fever with thrombocytopenia syndrome. J Infect Dis. 2019;220(1):23–27. doi: 10.1093/infdis/jiz054
   PubMed Web of Science ®Google Scholar
• Song P, Zheng N, Liu Y, et al. Deficient humoral responses and disrupted B-cell immunity are associated with fatal SFTSV infection. Nat Commun. 2018;9(1). doi: 10.1038/s41467-018-05746-9
   Google Scholar
• Li M-M, Zhang W-J, Weng X-F, et al. CD4 T cell loss and Th2 and Th17 bias are associated with the severity of severe fever with thrombocytopenia syndrome (SFTS). Clin Immunol. 2018;195:8–17. doi: 10.1016/j.clim.2018.07.009
   PubMed Web of Science ®Google Scholar
• Yi X, Li W, Li H, et al. Circulating regulatory T cells in patients with severe fever with thrombocytopenia syndrome. Infect Dis (Auckl). 2015;47(5):294–301. doi: 10.3109/00365548.2014.987812
   Web of Science ®Google Scholar
• Li XK, Lu QB, Chen WW, et al. Arginine deficiency is involved in thrombocytopenia and immunosuppression in severe fever with thrombocytopenia syndrome. Sci Transl Med. 2018;10(459):10. doi: 10.1126/scitranslmed.aat4162
   Web of Science ®Google Scholar
• Xu H, Wei Y, Ma H, et al. Alterations of gut microbiome in the patients with severe fever with thrombocytopenia syndrome. Front Microbiol. 2018;9:2315. doi: 10.3389/fmicb.2018.02315
   PubMed Web of Science ®Google Scholar
• Xie J, Li H, Zhang X, et al. Akkermansia muciniphila protects mice against an emerging tick-borne viral pathogen. Nat Microbiol. 2023;8(1):91–106. doi: 10.1038/s41564-022-01279-6
   PubMed Web of Science ®Google Scholar
• Zhang L, Wang D, Shi P, et al. A naturally isolated symbiotic bacterium suppresses flavivirus transmission by Aedes mosquitoes. Science. 2024;384(6693):eadn9524. doi: 10.1126/science.adn9524
   PubMed Web of Science ®Google Scholar
• Sun Y, Chen C, Zeng C, et al. Severe fever with thrombocytopenia syndrome virus infection shapes gut microbiome of the tick vector haemaphysalis longicornis. Parasit Vectors. 2024;17(1):107. doi: 10.1186/s13071-024-06204-w
   PubMed Web of Science ®Google Scholar
• Tchouassi DP, Muturi EJ, Arum SO, et al. Host species and site of collection shape the microbiota of Rift Valley fever vectors in Kenya. PLOS Negl Trop Dis. 2019;13(6):e0007361. doi: 10.1371/journal.pntd.0007361
   PubMed Web of Science ®Google Scholar
• Gowen BB, Hickerson BT. Hemorrhagic fever of bunyavirus etiology: disease models and progress towards new therapies. J Microbiol. 2017;55(3):183–195. doi: 10.1007/s12275-017-7029-8
   PubMed Web of Science ®Google Scholar
• Gai ZT, Zhang Y, Liang MF, et al. Clinical progress and risk factors for death in severe fever with thrombocytopenia syndrome patients. J Infect Dis. 2012;206(7):1095–1102. doi: 10.1093/infdis/jis472
   PubMed Web of Science ®Google Scholar
• Li YH, Wang XH, Huang WW, et al. RETRACTED: severe fever with thrombocytopenia syndrome virus induces platelet activation and apoptosis via a reactive oxygen species-dependent pathway. Redox Biol. 2023;65:102837. doi: 10.1016/j.redox.2023.102837
   PubMed Web of Science ®Google Scholar
• Fang L, Yu S, Tian X, et al. Severe fever with thrombocytopenia syndrome virus replicates in platelets and enhances platelet activation. J Thromb Haemost. 2023;21(5):1336–1351. doi: 10.1016/j.jtha.2023.02.006
   PubMed Web of Science ®Google Scholar